ASIM Joins Coalition in Effort to Bring Tobacco Industry Under FDA Control

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 3
Volume 4
Issue 3

WASHINGTON--The American Society of Internal Medicine (ASIM) joined the Coalition on Smoking OR Health in its effort to create FDA oversight of the tobacco industry. ASIM's policy on tobacco supports stronger cigarette labels,

WASHINGTON--The American Society of Internal Medicine (ASIM) joinedthe Coalition on Smoking OR Health in its effort to create FDAoversight of the tobacco industry. ASIM's policy on tobacco supportsstronger cigarette labels, increasing the legal age to buy tobaccoproducts to 21, and a ban on tobacco advertising or at least eliminationof its tax deductibility.

Recent Videos
Performance status, age, and comorbidities may impact benefit seen with immunotherapy vs chemotherapy in patients with breast cancer.
Developing odronextamab combinations following CAR T-cell therapy failure may help elicit responses in patients with diffuse large B-cell lymphoma.
An “avalanche of funding” has propelled the kidney cancer field forward, says Jason Muhitch, PhD.
4 experts are featured in this series.
4 experts are featured in this series.
3 experts in this video
Related Content